CLAUDE CURRAN: Open Payments
NPI 1609980135 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 90 payments from 8 companies in 2025. Trend: 2023 $1,692 · 2024 $1,937 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $743 |
| Otsuka America Pharmaceutical, Inc. | 12 | $424 |
| Vanda Pharmaceuticals Inc. | 10 | $285 |
| Alkermes, Inc. | 20 | $268 |
| Lundbeck LLC | 11 | $168 |
| Janssen Pharmaceuticals, Inc | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| ABBVIE INC. | 1 | $15 |
Products named: CAPLYTA, REXULTI, FANAPT, ARISTADA, INVEGA SUSTENNA, COBENFY, VIVITROL, VRAYLAR.
Industry payments across MA — which companies pay providers there.
